138 related articles for article (PubMed ID: 36434416)
1. The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned.
Al Shabasy S; Roudijk B; Abbassi M; Finch A; Stolk E; Farid S
Pharmacoeconomics; 2023 Mar; 41(3):329-338. PubMed ID: 36434416
[TBL] [Abstract][Full Text] [Related]
2. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.
Ludwig K; von der Schulenburg JG; Greiner W
Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389
[TBL] [Abstract][Full Text] [Related]
3. The EQ-5D-5L Valuation Study in Egypt.
Al Shabasy S; Abbassi M; Finch A; Roudijk B; Baines D; Farid S
Pharmacoeconomics; 2022 Apr; 40(4):433-447. PubMed ID: 34786590
[TBL] [Abstract][Full Text] [Related]
4. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration.
Finch AP; Meregaglia M; Ciani O; Roudijk B; Jommi C
Soc Sci Med; 2022 Jan; 292():114519. PubMed ID: 34736804
[TBL] [Abstract][Full Text] [Related]
5. Quality Control Process for EQ-5D-5L Valuation Studies.
Ramos-Goñi JM; Oppe M; Slaap B; Busschbach JJ; Stolk E
Value Health; 2017 Mar; 20(3):466-473. PubMed ID: 28292492
[TBL] [Abstract][Full Text] [Related]
6. EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study.
Al Shabasy S; Abbassi M; Farid S
BMJ Open; 2021 Dec; 11(12):e051727. PubMed ID: 34949616
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
[TBL] [Abstract][Full Text] [Related]
8. The EQ-5D-5L Valuation Study in Egypt.
Al Shabasy SA; Abbassi MM; Finch AP; Baines D; Farid SF
Pharmacoeconomics; 2021 May; 39(5):549-561. PubMed ID: 33709283
[TBL] [Abstract][Full Text] [Related]
9. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
10. Dutch Tariff for the Five-Level Version of EQ-5D.
M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
[TBL] [Abstract][Full Text] [Related]
11. Randomised comparison of online interviews versus face-to-face interviews to value health states.
Peasgood T; Bourke M; Devlin N; Rowen D; Yang Y; Dalziel K
Soc Sci Med; 2023 Apr; 323():115818. PubMed ID: 36940582
[TBL] [Abstract][Full Text] [Related]
12. Cross-Attribute Level Effects Models for Modeling Modified 5-Level Version of EQ-5D Health State Values: Is Less Still More?
Yang Z; Rand K; Busschbach J; Luo N
Value Health; 2023 Jun; 26(6):865-872. PubMed ID: 36566885
[TBL] [Abstract][Full Text] [Related]
13. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off.
Jiang R; Shaw J; Mühlbacher A; Lee TA; Walton S; Kohlmann T; Norman R; Pickard AS
Qual Life Res; 2021 May; 30(5):1433-1444. PubMed ID: 33247810
[TBL] [Abstract][Full Text] [Related]
14. Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study.
Al-Jedai A; Almudaiheem H; Al-Salamah T; Aldosari M; Almutairi AR; Almogbel Y; AlRuthia Y; Althemery AU; Alluhidan M; Roudijk B; Purba FD; Awad N; O'jeil R
Value Health; 2024 May; 27(5):552-561. PubMed ID: 38342365
[TBL] [Abstract][Full Text] [Related]
15. Valuing the EQ Health and Wellbeing Short Using Time Trade-Off and a Discrete Choice Experiment: A Feasibility Study.
Mukuria C; Peasgood T; McDool E; Norman R; Rowen D; Brazier J
Value Health; 2023 Jul; 26(7):1073-1084. PubMed ID: 36805577
[TBL] [Abstract][Full Text] [Related]
16. United States Valuation of EQ-5D-5L Health States Using an International Protocol.
Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV
Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935
[TBL] [Abstract][Full Text] [Related]
17. Exploring non-iterative time trade-off methods for valuation of EQ-5D-5L health states.
Yang Z; Rand K; Stolk E; Busschbach J; Luo N
Eur J Health Econ; 2023 Dec; ():. PubMed ID: 38104294
[TBL] [Abstract][Full Text] [Related]
18. UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol.
Rowen D; Mukuria C; Bray N; Carlton J; Cooper S; Longworth L; Meads D; O'Neill C; Yang Y
Value Health; 2023 Nov; 26(11):1625-1635. PubMed ID: 37722593
[TBL] [Abstract][Full Text] [Related]
19. Using Time Trade-Off Values to Estimate EQ-5D-Y Value Sets: An Exploratory Study.
Yang Z; Jiang J; Wang P; Wu J; Fang Y; Feng D; Xi X; Luo N
Value Health; 2023 Jul; 26(7):968-973. PubMed ID: 36921897
[TBL] [Abstract][Full Text] [Related]
20. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments.
Augustovski F; Belizán M; Gibbons L; Reyes N; Stolk E; Craig BM; Tejada RA
Value Health; 2020 Jul; 23(7):880-888. PubMed ID: 32762989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
